Therapeutic Asset Ratings

474 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Nggt002 Phenylketonurias	NGGT INC.	P1/2	CCC (54)
Recombinant Human Il12/15-Pdl1B Oncolytic Hsv-1 ) Primary Hepatocellular Carcinoma	CNBG-Virogin Biotech (Shanghai) Ltd.	P1/2	CCC (54)
ab-1005 PARKINSON DISEASE (Disorder)	Bayer	P2	CCC (53)
Adv-Tk Prostate Cancer (Adenocarcinoma)	Candel Therapeutics, Inc.	P2	CCC (53)
A REPLICATION-DEFICIENT RECOMBINANT ADENOVIRUS, SEROTYPE 5, ENCODING MULTIPLE HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ISOFORMS Coronary Artery Disease	XyloCor Therapeutics, Inc.	P2	CCC (53)
A REPLICATION-DEFICIENT RECOMBINANT ADENOVIRUS, SEROTYPE 5, ENCODING MULTIPLE HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ISOFORMS Refractory Angina	XyloCor Therapeutics, Inc.	P2	CCC (53)
db107-rrv Anaplastic Astrocytoma	Ashish Shah	P2	CCC (53)
g207 Anaplastic Astrocytoma of Brain	Pediatric Brain Tumor Consortium	P2	CCC (53)
g207 Anaplastic Glioma	Pediatric Brain Tumor Consortium	P2	CCC (53)
g207 Giant Cell Glioblastoma	Pediatric Brain Tumor Consortium	P2	CCC (53)
g207 Glioblastoma	Pediatric Brain Tumor Consortium	P2	CCC (53)
g207 Glioblastoma Multiforme	Pediatric Brain Tumor Consortium	P2	CCC (53)
g207 High Grade Glioma	Pediatric Brain Tumor Consortium	P2	CCC (53)
g207 Malignant Glioma of Brain	Pediatric Brain Tumor Consortium	P2	CCC (53)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101) CRC	Jun Huang	P2	CCC (53)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101) Genital Neoplasms, Female	Liu Zi	P2	CCC (53)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101) Liver Metastasis Colon Cancer	Jun Huang	P2	CCC (53)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101) Rectal Neoplasms	Chongqing University Cancer Hospital	P2	CCC (53)
Genetic: Mb-105 Lymphoma, T-Cell	March Biosciences Inc	P2	CCC (53)
gnt0003 Crigler-Najjar Syndrome	Genethon	P2	CCC (53)
Grt-C901 Colonic Neoplasms	Gritstone bio, Inc.	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Anaplastic Large Cell Lymphoma, ALK-Negative	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Anaplastic Large Cell Lymphoma, ALK-Positive	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Apocrine Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Carcinoma Arising From Cylindroma	National Cancer Institute (NCI)	P2	CCC (53)

Showing 76 to 100 of 474 assets

PreviousPage 4 of 19Next